Geode Capital Management’s Petros Pharmaceuticals PTPI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-4,327
| Closed | -$7.48K | – | 4506 |
|
2025
Q1 | $7.48K | Buy |
4,327
+2,880
| +199% | +$4.98K | ﹤0.01% | 4445 |
|
2024
Q4 | $14.3K | Sell |
1,447
-54
| -4% | -$532 | ﹤0.01% | 4413 |
|
2024
Q3 | $13.4K | Buy |
1,501
+286
| +24% | +$2.55K | ﹤0.01% | 4442 |
|
2024
Q2 | $13.9K | Buy |
1,215
+795
| +189% | +$9.12K | ﹤0.01% | 4511 |
|
2024
Q1 | $15.5K | Hold |
420
| – | – | ﹤0.01% | 4511 |
|
2023
Q4 | $14.9K | Hold |
420
| – | – | ﹤0.01% | 4554 |
|
2023
Q3 | $17.4K | Buy |
+420
| New | +$17.4K | ﹤0.01% | 4648 |
|
2022
Q4 | – | Sell |
-307
| Closed | -$39K | – | 4924 |
|
2022
Q3 | $39K | Buy |
307
+6
| +2% | +$762 | ﹤0.01% | 4813 |
|
2022
Q2 | $61K | Buy |
301
+21
| +8% | +$4.26K | ﹤0.01% | 4731 |
|
2022
Q1 | $109K | Buy |
280
+45
| +19% | +$17.5K | ﹤0.01% | 4630 |
|
2021
Q4 | $195K | Buy |
235
+140
| +147% | +$116K | ﹤0.01% | 4485 |
|
2021
Q3 | $47K | Hold |
95
| – | – | ﹤0.01% | 4792 |
|
2021
Q2 | $74K | Buy |
95
+38
| +67% | +$29.6K | ﹤0.01% | 4610 |
|
2021
Q1 | $52K | Buy |
+57
| New | +$52K | ﹤0.01% | 4397 |
|